Download Files:
CD2314
SKU
HY-108533-10 mg
Category Reference compound
Tags Cancer, Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor, RAR/RXR
$600 – $960
Products Details
Product Description
– CD2314 is a potent and selective RARβ receptor agonist with a Kd of 195 nM in S91 melanoma cells[1].
Web ID
– HY-108533
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C23H24O2S
References
– [1]Spanjaard RA, et al. Specific activation of retinoic acid receptors (RARs) and retinoid X receptors reveals a unique role for RARgamma in induction of differentiation and apoptosis of S91 melanoma cells. J Biol Chem. 1997 Jul 25;272(30):18990-9.
CAS Number
– 170355-37-0
Molecular Weight
– 364.50
Compound Purity
– 99.0
SMILES
– O=C(C1=CSC(C2=CC=C3C=C4C(C)(C)CCC(C)(C)C4=CC3=C2)=C1)O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– RAR/RXR
Pathway
– Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.